The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 30, 2020
Filed:
May. 30, 2016
Applicants:
National University Corporation Kobe University, Hyogo, JP;
Osaka University, Osaka, JP;
Inventors:
Toshiro Shirakawa, Hyogo, JP;
Takane Katayama, Kyoto, JP;
Yoshiko Hashii, Osaka, JP;
Keiichi Ozono, Osaka, JP;
Assignees:
NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY, Hyogo, JP;
OSAKA UNIVERSITY, Osaka, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/745 (2015.01); C07K 19/00 (2006.01); C07K 14/195 (2006.01); C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 39/00 (2006.01); C07K 14/47 (2006.01); C12N 15/74 (2006.01); C07K 14/82 (2006.01);
U.S. Cl.
CPC ...
A61K 35/745 (2013.01); A61K 38/00 (2013.01); A61K 38/1764 (2013.01); A61K 39/0011 (2013.01); C07K 14/195 (2013.01); C07K 14/4748 (2013.01); C07K 19/00 (2013.01); C12N 15/09 (2013.01); C12N 15/746 (2013.01); A61K 2039/522 (2013.01); A61K 2039/523 (2013.01); C07K 14/82 (2013.01);
Abstract
A cancer vaccine that can be orally administered can be provided through the use of a transformedcapable of expressing and displaying a WT1 protein. The WT1 protein expressed and displayed by the transformedis a protein covering most of a WT1 protein unlike a WT1 peptide vaccine restricted to a certain HLA. A cancer vaccine using the transformedas an active ingredient is applicable to patients of various HLA types.